Results 191 to 200 of about 514,797 (263)
Striking a balance: how the gut microbiome shapes the fate of intestinal CD4+ T cells. [PDF]
Till JM, Brock OD, Ahern PP.
europepmc +1 more source
A double‐layered shell‐core microneedle patch is developed to co‐deliver FOLFIRINOX, surufatinib, and anti‐PD‐1 for localized chemo‐immunotherapy of PDAC. This strategy achieves sustained tumor suppression, reduces metastasis, and reprograms the TME by enhancing CD8+ T‐cell infiltration and inhibiting Tregs and M2 macrophages infiltration, while ...
Tingting Kong +13 more
wiley +1 more source
Comprehensive Immune-Phenotyping of Peripheral Lymphocytes in Coronary Artery Disease Reveals Potential Roles of Effector Memory and PD-1⁺ CD4⁺ T Cells. [PDF]
Huang X +8 more
europepmc +1 more source
Sustained delivery of a shingles subunit vaccine from an injectable polymer–nanoparticle hydrogel enhanced the potency, durability, and breadth of immune responses in aged mice while minimizing inflammatory cytokine production and reactogenicity. This strategy decouples immunogenicity from reactogenicity and offers a promising approach to improve ...
Ye Eun Song +5 more
wiley +1 more source
CD4⁺ T cells confer transplantable rejuvenation via Rivers of telomeres
Lanna A, Valvo S, Dustin ML, Rinaldi F.
europepmc +1 more source
CD4 T cells correlate with better prognosis in medulloblastoma. [PDF]
Zhang J +14 more
europepmc +1 more source
IMM‐H018, a dual IDO1/NE inhibitor, demonstrates potent therapeutic efficacy in sepsis by simultaneously targeting excessive inflammation and immune dysfunction. It prevents both primary and secondary sepsis through anti‐inflammatory, immune‐restoring, and renoprotective mechanisms, reducing organ damage, improving immune homeostasis, preserving kidney
Yi Zhou +11 more
wiley +1 more source
Pro-Inflammatory c-Met<sup>+</sup> CD4 T Cells in Multiple Sclerosis. [PDF]
Breville G +6 more
europepmc +1 more source
Dual Blockade of LILRB1 and LILRB2 Enhances Antiviral Immune Responses in SIV Infection
Dual LILRB1/B2 blockade with mac20G10 reshapes myeloid activation during acute SIV infection by targeting LILRB1 and LILRB2 on myeloid cells. This treatment enhances CD80 expression on selected myeloid subsets and increases plasma IFN‐λ, IL‐8, and IL‐1RA.
Florian Meurisse +20 more
wiley +1 more source
Integrated transcriptome study reveals a stress response state CD4 +T cells related to immune tolerance in breast cancer. [PDF]
Gu J +15 more
europepmc +1 more source

